Loading…
The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review
ABSTRACT Objective: To describe the current state of the art in the therapeutic administration of botulinum toxin with indications, efficacy, and safety profile for children and adolescents with cerebral palsy. Data source: An integrative review was conducted. The MEDLINE/PubMed database was searche...
Saved in:
Published in: | Revista Paulista de Pediatria 2024, Vol.42 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4443-5751b20a0a11a4ec9f313b466ffcbf1ca15e9c875db9d896b93aaebcf68a0d753 |
---|---|
cites | cdi_FETCH-LOGICAL-c4443-5751b20a0a11a4ec9f313b466ffcbf1ca15e9c875db9d896b93aaebcf68a0d753 |
container_end_page | |
container_issue | |
container_start_page | |
container_title | Revista Paulista de Pediatria |
container_volume | 42 |
creator | Dorf, Sandro Rachevsky Fonseca, Adriana Rodrigues Sztajnbok, Flávio Roberto Oliveira, Thiffany Rodrigues Delfino de Basttistella, Linamara Rizzo |
description | ABSTRACT Objective: To describe the current state of the art in the therapeutic administration of botulinum toxin with indications, efficacy, and safety profile for children and adolescents with cerebral palsy. Data source: An integrative review was conducted. The MEDLINE/PubMed database was searched twice within the last decade using distinct terms, and only studies written in the English language were included. The study population was limited to those aged 0–18 years. Articles that were duplicates or lacked sufficient methodology information were excluded. Data synthesis: We found 256 articles, of which 105 were included. Among the included studies, most were conducted in developed countries. Botulinum toxin demonstrated good safety and efficacy in reducing spasticity, particularly when administered by a multidisciplinary rehabilitation team. It is primarily utilized to improve gait and upper limb function, facilitate hygiene care, reduce pain, prevent musculoskeletal deformities, and even decrease sialorrhea in patients without a functional prognosis for walking. Conclusions: The administration of botulinum toxin is safe and efficacious, especially when combined with a multi-professional rehabilitation team approach, which increases the probability of functional improvement. It can also be beneficial for patients with significant functional impairments to help with daily care tasks, such as hygiene, dressing, and reducing sialorrhea. Pediatricians must be familiar with this treatment and its indications to attend to and refer patients promptly when necessary, and to exploit their neuroplasticity. Further research on this topic is required in developing countries.
RESUMO Objetivo: Descrever o estado da arte em aplicação terapêutica de toxina botulínica com indicações, eficácia e perfil de segurança em crianças e adolescentes com paralisia cerebral. Fontes de dados: Realizada revisão integrativa através de busca na base de dados MEDLINE/PubMed em dois momentos nos últimos 10 anos, e termos distintos, em inglês, numa população entre 0 e 18 anos de idade. Excluiu-se artigos duplicados ou com informações insuficientes de metodologia. Síntese dos dados: 256 artigos foram encontrados e 105 foram incluídos, sendo a maior parte realizados em países desenvolvidos. A toxina botulínica mostrou boa segurança e efetividade na redução da espasticidade, especialmente administrada por uma equipe de reabilitação multiprofissional, usada principalmente para: melhora da m |
doi_str_mv | 10.1590/1984-0462/2024/42/2023093 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10962635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_7b44092baebd45ca9867c59b27f038a4</doaj_id><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_10962635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4443-5751b20a0a11a4ec9f313b466ffcbf1ca15e9c875db9d896b93aaebcf68a0d753</originalsourceid><addsrcrecordid>eNpVkd1qGzEQhUVpoG7Sd1AfYGtp9bOr3pQS-hMI5Ca5FiPtyFZYr4xWdhrow2dlh0BAcDQ6Mx-SDiFfOfvGlWFrbnrZMKnbdctauZYnFcyID2T15n0kK8aZaJjq20_k8zw_MqYZ192K_L_fIp0LFKQp0LIUkAuNU91m2OOhRE9h2MUpziVDiWmqjS6Vwxinw46W9G_pXpbfxnHIONGnWLbUY0aXYaR7GOfn7xRqT8FNRRyRZjxGfLoiF2Gx8curXpKH37_ur_82t3d_bq5_3jZeSika1SnuWgYMOAeJ3gTBhZNah-Bd4B64QuP7Tg3ODL3RzggAdD7oHtjQKXFJbs7cIcGj3ee4g_xsE0R7Okh5Y5dXRz-i7ZyUzLRumR-k8mB63XllXNsFJnqQC-vHmbU_uB0OHqflW8Z30PfOFLd2k46WM6NbLeptzJngc5rnjOFtmDNbQ7U1OFuDszVUK09aQxUvh_qZow</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review</title><source>PubMed Central (Open Access)</source><source>SciELO</source><creator>Dorf, Sandro Rachevsky ; Fonseca, Adriana Rodrigues ; Sztajnbok, Flávio Roberto ; Oliveira, Thiffany Rodrigues Delfino de ; Basttistella, Linamara Rizzo</creator><creatorcontrib>Dorf, Sandro Rachevsky ; Fonseca, Adriana Rodrigues ; Sztajnbok, Flávio Roberto ; Oliveira, Thiffany Rodrigues Delfino de ; Basttistella, Linamara Rizzo</creatorcontrib><description>ABSTRACT Objective: To describe the current state of the art in the therapeutic administration of botulinum toxin with indications, efficacy, and safety profile for children and adolescents with cerebral palsy. Data source: An integrative review was conducted. The MEDLINE/PubMed database was searched twice within the last decade using distinct terms, and only studies written in the English language were included. The study population was limited to those aged 0–18 years. Articles that were duplicates or lacked sufficient methodology information were excluded. Data synthesis: We found 256 articles, of which 105 were included. Among the included studies, most were conducted in developed countries. Botulinum toxin demonstrated good safety and efficacy in reducing spasticity, particularly when administered by a multidisciplinary rehabilitation team. It is primarily utilized to improve gait and upper limb function, facilitate hygiene care, reduce pain, prevent musculoskeletal deformities, and even decrease sialorrhea in patients without a functional prognosis for walking. Conclusions: The administration of botulinum toxin is safe and efficacious, especially when combined with a multi-professional rehabilitation team approach, which increases the probability of functional improvement. It can also be beneficial for patients with significant functional impairments to help with daily care tasks, such as hygiene, dressing, and reducing sialorrhea. Pediatricians must be familiar with this treatment and its indications to attend to and refer patients promptly when necessary, and to exploit their neuroplasticity. Further research on this topic is required in developing countries.
RESUMO Objetivo: Descrever o estado da arte em aplicação terapêutica de toxina botulínica com indicações, eficácia e perfil de segurança em crianças e adolescentes com paralisia cerebral. Fontes de dados: Realizada revisão integrativa através de busca na base de dados MEDLINE/PubMed em dois momentos nos últimos 10 anos, e termos distintos, em inglês, numa população entre 0 e 18 anos de idade. Excluiu-se artigos duplicados ou com informações insuficientes de metodologia. Síntese dos dados: 256 artigos foram encontrados e 105 foram incluídos, sendo a maior parte realizados em países desenvolvidos. A toxina botulínica mostrou boa segurança e efetividade na redução da espasticidade, especialmente administrada por uma equipe de reabilitação multiprofissional, usada principalmente para: melhora da marcha e da função dos membros superiores, facilitação dos cuidados de higiene, analgesia e prevenção de deformidades musculoesqueléticas, além de redução da sialorreia, inclusive em pacientes sem prognóstico funcional de marcha. Conclusões: A aplicação de toxina botulínica foi efetiva e segura, principalmente quando atrelada a uma abordagem por equipe de reabilitação multiprofissional, o que aumenta as chances de melhora funcional. Mostrou-se benéfica também para pacientes com grandes comprometimentos funcionais para facilitar os seus cuidados diários em relação à higiene, colocar e tirar roupas e redução da sialorreia. O pediatra deve estar familiarizado com esse tratamento e suas indicações para atender e direcionar pacientes o mais breve possível quando indicado e aproveitar o máximo de neuroplasticidade. Há necessidade de investimentos em mais pesquisas sobre este tema em países em desenvolvimento.</description><identifier>ISSN: 0103-0582</identifier><identifier>EISSN: 1984-0462</identifier><identifier>DOI: 10.1590/1984-0462/2024/42/2023093</identifier><language>eng</language><publisher>Sociedade de Pediatria de São Paulo</publisher><subject>Botulinum toxin ; Cerebral palsy ; Rehabilitation ; Review ; Spasticity</subject><ispartof>Revista Paulista de Pediatria, 2024, Vol.42</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4443-5751b20a0a11a4ec9f313b466ffcbf1ca15e9c875db9d896b93aaebcf68a0d753</citedby><cites>FETCH-LOGICAL-c4443-5751b20a0a11a4ec9f313b466ffcbf1ca15e9c875db9d896b93aaebcf68a0d753</cites><orcidid>0009-0000-3382-3319 ; 0000-0002-3536-3552 ; 0000-0001-5275-0733 ; 0000-0001-6739-8760 ; 0000-0002-7301-9664</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962635/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962635/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,4010,27904,27905,27906,53772,53774</link.rule.ids></links><search><creatorcontrib>Dorf, Sandro Rachevsky</creatorcontrib><creatorcontrib>Fonseca, Adriana Rodrigues</creatorcontrib><creatorcontrib>Sztajnbok, Flávio Roberto</creatorcontrib><creatorcontrib>Oliveira, Thiffany Rodrigues Delfino de</creatorcontrib><creatorcontrib>Basttistella, Linamara Rizzo</creatorcontrib><title>The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review</title><title>Revista Paulista de Pediatria</title><description>ABSTRACT Objective: To describe the current state of the art in the therapeutic administration of botulinum toxin with indications, efficacy, and safety profile for children and adolescents with cerebral palsy. Data source: An integrative review was conducted. The MEDLINE/PubMed database was searched twice within the last decade using distinct terms, and only studies written in the English language were included. The study population was limited to those aged 0–18 years. Articles that were duplicates or lacked sufficient methodology information were excluded. Data synthesis: We found 256 articles, of which 105 were included. Among the included studies, most were conducted in developed countries. Botulinum toxin demonstrated good safety and efficacy in reducing spasticity, particularly when administered by a multidisciplinary rehabilitation team. It is primarily utilized to improve gait and upper limb function, facilitate hygiene care, reduce pain, prevent musculoskeletal deformities, and even decrease sialorrhea in patients without a functional prognosis for walking. Conclusions: The administration of botulinum toxin is safe and efficacious, especially when combined with a multi-professional rehabilitation team approach, which increases the probability of functional improvement. It can also be beneficial for patients with significant functional impairments to help with daily care tasks, such as hygiene, dressing, and reducing sialorrhea. Pediatricians must be familiar with this treatment and its indications to attend to and refer patients promptly when necessary, and to exploit their neuroplasticity. Further research on this topic is required in developing countries.
RESUMO Objetivo: Descrever o estado da arte em aplicação terapêutica de toxina botulínica com indicações, eficácia e perfil de segurança em crianças e adolescentes com paralisia cerebral. Fontes de dados: Realizada revisão integrativa através de busca na base de dados MEDLINE/PubMed em dois momentos nos últimos 10 anos, e termos distintos, em inglês, numa população entre 0 e 18 anos de idade. Excluiu-se artigos duplicados ou com informações insuficientes de metodologia. Síntese dos dados: 256 artigos foram encontrados e 105 foram incluídos, sendo a maior parte realizados em países desenvolvidos. A toxina botulínica mostrou boa segurança e efetividade na redução da espasticidade, especialmente administrada por uma equipe de reabilitação multiprofissional, usada principalmente para: melhora da marcha e da função dos membros superiores, facilitação dos cuidados de higiene, analgesia e prevenção de deformidades musculoesqueléticas, além de redução da sialorreia, inclusive em pacientes sem prognóstico funcional de marcha. Conclusões: A aplicação de toxina botulínica foi efetiva e segura, principalmente quando atrelada a uma abordagem por equipe de reabilitação multiprofissional, o que aumenta as chances de melhora funcional. Mostrou-se benéfica também para pacientes com grandes comprometimentos funcionais para facilitar os seus cuidados diários em relação à higiene, colocar e tirar roupas e redução da sialorreia. O pediatra deve estar familiarizado com esse tratamento e suas indicações para atender e direcionar pacientes o mais breve possível quando indicado e aproveitar o máximo de neuroplasticidade. Há necessidade de investimentos em mais pesquisas sobre este tema em países em desenvolvimento.</description><subject>Botulinum toxin</subject><subject>Cerebral palsy</subject><subject>Rehabilitation</subject><subject>Review</subject><subject>Spasticity</subject><issn>0103-0582</issn><issn>1984-0462</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkd1qGzEQhUVpoG7Sd1AfYGtp9bOr3pQS-hMI5Ca5FiPtyFZYr4xWdhrow2dlh0BAcDQ6Mx-SDiFfOfvGlWFrbnrZMKnbdctauZYnFcyID2T15n0kK8aZaJjq20_k8zw_MqYZ192K_L_fIp0LFKQp0LIUkAuNU91m2OOhRE9h2MUpziVDiWmqjS6Vwxinw46W9G_pXpbfxnHIONGnWLbUY0aXYaR7GOfn7xRqT8FNRRyRZjxGfLoiF2Gx8curXpKH37_ur_82t3d_bq5_3jZeSika1SnuWgYMOAeJ3gTBhZNah-Bd4B64QuP7Tg3ODL3RzggAdD7oHtjQKXFJbs7cIcGj3ee4g_xsE0R7Okh5Y5dXRz-i7ZyUzLRumR-k8mB63XllXNsFJnqQC-vHmbU_uB0OHqflW8Z30PfOFLd2k46WM6NbLeptzJngc5rnjOFtmDNbQ7U1OFuDszVUK09aQxUvh_qZow</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Dorf, Sandro Rachevsky</creator><creator>Fonseca, Adriana Rodrigues</creator><creator>Sztajnbok, Flávio Roberto</creator><creator>Oliveira, Thiffany Rodrigues Delfino de</creator><creator>Basttistella, Linamara Rizzo</creator><general>Sociedade de Pediatria de São Paulo</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0000-3382-3319</orcidid><orcidid>https://orcid.org/0000-0002-3536-3552</orcidid><orcidid>https://orcid.org/0000-0001-5275-0733</orcidid><orcidid>https://orcid.org/0000-0001-6739-8760</orcidid><orcidid>https://orcid.org/0000-0002-7301-9664</orcidid></search><sort><creationdate>2024</creationdate><title>The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review</title><author>Dorf, Sandro Rachevsky ; Fonseca, Adriana Rodrigues ; Sztajnbok, Flávio Roberto ; Oliveira, Thiffany Rodrigues Delfino de ; Basttistella, Linamara Rizzo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4443-5751b20a0a11a4ec9f313b466ffcbf1ca15e9c875db9d896b93aaebcf68a0d753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Botulinum toxin</topic><topic>Cerebral palsy</topic><topic>Rehabilitation</topic><topic>Review</topic><topic>Spasticity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dorf, Sandro Rachevsky</creatorcontrib><creatorcontrib>Fonseca, Adriana Rodrigues</creatorcontrib><creatorcontrib>Sztajnbok, Flávio Roberto</creatorcontrib><creatorcontrib>Oliveira, Thiffany Rodrigues Delfino de</creatorcontrib><creatorcontrib>Basttistella, Linamara Rizzo</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Revista Paulista de Pediatria</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dorf, Sandro Rachevsky</au><au>Fonseca, Adriana Rodrigues</au><au>Sztajnbok, Flávio Roberto</au><au>Oliveira, Thiffany Rodrigues Delfino de</au><au>Basttistella, Linamara Rizzo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review</atitle><jtitle>Revista Paulista de Pediatria</jtitle><date>2024</date><risdate>2024</risdate><volume>42</volume><issn>0103-0582</issn><eissn>1984-0462</eissn><abstract>ABSTRACT Objective: To describe the current state of the art in the therapeutic administration of botulinum toxin with indications, efficacy, and safety profile for children and adolescents with cerebral palsy. Data source: An integrative review was conducted. The MEDLINE/PubMed database was searched twice within the last decade using distinct terms, and only studies written in the English language were included. The study population was limited to those aged 0–18 years. Articles that were duplicates or lacked sufficient methodology information were excluded. Data synthesis: We found 256 articles, of which 105 were included. Among the included studies, most were conducted in developed countries. Botulinum toxin demonstrated good safety and efficacy in reducing spasticity, particularly when administered by a multidisciplinary rehabilitation team. It is primarily utilized to improve gait and upper limb function, facilitate hygiene care, reduce pain, prevent musculoskeletal deformities, and even decrease sialorrhea in patients without a functional prognosis for walking. Conclusions: The administration of botulinum toxin is safe and efficacious, especially when combined with a multi-professional rehabilitation team approach, which increases the probability of functional improvement. It can also be beneficial for patients with significant functional impairments to help with daily care tasks, such as hygiene, dressing, and reducing sialorrhea. Pediatricians must be familiar with this treatment and its indications to attend to and refer patients promptly when necessary, and to exploit their neuroplasticity. Further research on this topic is required in developing countries.
RESUMO Objetivo: Descrever o estado da arte em aplicação terapêutica de toxina botulínica com indicações, eficácia e perfil de segurança em crianças e adolescentes com paralisia cerebral. Fontes de dados: Realizada revisão integrativa através de busca na base de dados MEDLINE/PubMed em dois momentos nos últimos 10 anos, e termos distintos, em inglês, numa população entre 0 e 18 anos de idade. Excluiu-se artigos duplicados ou com informações insuficientes de metodologia. Síntese dos dados: 256 artigos foram encontrados e 105 foram incluídos, sendo a maior parte realizados em países desenvolvidos. A toxina botulínica mostrou boa segurança e efetividade na redução da espasticidade, especialmente administrada por uma equipe de reabilitação multiprofissional, usada principalmente para: melhora da marcha e da função dos membros superiores, facilitação dos cuidados de higiene, analgesia e prevenção de deformidades musculoesqueléticas, além de redução da sialorreia, inclusive em pacientes sem prognóstico funcional de marcha. Conclusões: A aplicação de toxina botulínica foi efetiva e segura, principalmente quando atrelada a uma abordagem por equipe de reabilitação multiprofissional, o que aumenta as chances de melhora funcional. Mostrou-se benéfica também para pacientes com grandes comprometimentos funcionais para facilitar os seus cuidados diários em relação à higiene, colocar e tirar roupas e redução da sialorreia. O pediatra deve estar familiarizado com esse tratamento e suas indicações para atender e direcionar pacientes o mais breve possível quando indicado e aproveitar o máximo de neuroplasticidade. Há necessidade de investimentos em mais pesquisas sobre este tema em países em desenvolvimento.</abstract><pub>Sociedade de Pediatria de São Paulo</pub><doi>10.1590/1984-0462/2024/42/2023093</doi><orcidid>https://orcid.org/0009-0000-3382-3319</orcidid><orcidid>https://orcid.org/0000-0002-3536-3552</orcidid><orcidid>https://orcid.org/0000-0001-5275-0733</orcidid><orcidid>https://orcid.org/0000-0001-6739-8760</orcidid><orcidid>https://orcid.org/0000-0002-7301-9664</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0103-0582 |
ispartof | Revista Paulista de Pediatria, 2024, Vol.42 |
issn | 0103-0582 1984-0462 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10962635 |
source | PubMed Central (Open Access); SciELO |
subjects | Botulinum toxin Cerebral palsy Rehabilitation Review Spasticity |
title | The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A54%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20state%20of%20the%20art%20in%20therapeutic%20administration%20of%20botulinum%20toxin%20in%20children%20with%20cerebral%20palsy:%20an%20integrative%20review&rft.jtitle=Revista%20Paulista%20de%20Pediatria&rft.au=Dorf,%20Sandro%20Rachevsky&rft.date=2024&rft.volume=42&rft.issn=0103-0582&rft.eissn=1984-0462&rft_id=info:doi/10.1590/1984-0462/2024/42/2023093&rft_dat=%3Cpubmedcentral_doaj_%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_10962635%3C/pubmedcentral_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4443-5751b20a0a11a4ec9f313b466ffcbf1ca15e9c875db9d896b93aaebcf68a0d753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |